AGIOS PHARMACEUTICALS INC

AGIOS PHARMACEUTICALS INC Share · US00847X1046 · AGIO · A1W2RM (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AGIOS PHARMACEUTICALS INC
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
22
7
0
0
No Price
01.05.2026 21:24
Current Prices from AGIOS PHARMACEUTICALS INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AGIO
USD
01.05.2026 21:24
28,00 USD
0,00 USD
IEXG: IEX
IEX
AGIO
USD
01.05.2026 19:59
28,17 USD
0,17 USD
+0,61 %
XLON: London
London
0HB0.L
USD
01.05.2026 15:02
27,30 USD
-0,70 USD
-2,50 %
XDUS: Düsseldorf
Düsseldorf
APIRSD46.DUSB
EUR
30.04.2026 17:31
23,80 EUR
-0,20 EUR
-0,83 %
XDQU: Quotrix
Quotrix
APIRSD46.DUSD
EUR
30.04.2026 05:31
23,40 EUR
-
Share Float & Liquidity
Free Float 92,87 %
Shares Float 54,41 M
Shares Outstanding 58,59 M
Invested Funds

The following funds have invested in AGIOS PHARMACEUTICALS INC:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
95,80
Percentage (%)
0,22 %
Company Profile for AGIOS PHARMACEUTICALS INC Share
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Company Data

Name AGIOS PHARMACEUTICALS INC
Company Agios Pharmaceuticals, Inc.
Symbol AGIO
Website https://www.agios.com
Primary Exchange XNAS NASDAQ
WKN A1W2RM
ISIN US00847X1046
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Brian M. Goff
Market Capitalization 2 Mrd.
Country United States of America
Currency USD
Employees 0,5 T
Address 88 Sidney Street, 02139-4169 Cambridge
IPO Date 2018-01-29
Dividends from 'AGIOS PHARMACEUTICALS INC'
Ex-Date Dividend per Share
15.03.2022 0,29 USD

Ticker Symbols

Name Symbol
Düsseldorf APIRSD46.DUSB
Frankfurt 8AP.F
London 0HB0.L
NASDAQ AGIO
Quotrix APIRSD46.DUSD
More Shares
Investors who hold AGIOS PHARMACEUTICALS INC also have the following shares in their portfolio:
A.MW CPAP U.E. EOD
A.MW CPAP U.E. EOD ETF
ALIGN TECHNOLOGIESLOGY INC
ALIGN TECHNOLOGIESLOGY INC Share
AMGEN INC
AMGEN INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
Heiwa Real Estate REIT, Inc.
Heiwa Real Estate REIT, Inc. Share
INTEL CORP
INTEL CORP Share
ISHARES € GOVT BOND 1-3YR UCITS ETF EUR (DIST)
ISHARES € GOVT BOND 1-3YR UCITS ETF EUR (DIST) ETF
LB.HESS.THR.CARRARA04U/20
LB.HESS.THR.CARRARA04U/20 Bond
MICROSOFT CORP
MICROSOFT CORP Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share